Pancreatic cancer research is getting a boost at UC Davis Comprehensive Cancer Center, thanks to a $2 million funding ...

Representatives pose for a group photo at the launch ceremony of the Shanghai Radiopharmaceutical Concept Verification Alliance in Pudong New Area, Shanghai on Jan 20. [Photo provided to ...

DIJON, France--(BUSINESS WIRE)--Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN: FR001400CM63; Mnemonic: ALOPM), a biopharmaceutical company specializing in precision medicine for the ...

Journal of Nuclear Medicine November 2025, jnumed.125.271249; DOI: https://doi.org/10.2967/jnumed.125.271249 Radiotheranostics holds transformative potential in ...

Scientists are turning venom, radioisotopes, engineered proteins, and AI into powerful new tools against cancer. From Amazonian scorpions yielding molecules that kill breast cancer cells as ...

Starpharma has signed its second deal in under a month. The company could be in line for milestone payments under the new agreement. Starpharma shares have performed well during September. The junior ...

Starpharma Holdings Ltd (ASX: SPL) shareholders are sitting on gains of more than 100% for the month after the company announced a new collaboration with Radiopharm Theranostics Ltd (ASX: RAD). The ...

Headshots of Nuclide Therapeutics cofounders Tim Witney (left) and Muhammet Tanc (right) standing outside. Nuclide Therapeutics cofounders Tim Witney (left) and Muhammet Tanc (right). Credit: Nuclide ...

Department of Chemistry, College of Chemistry and Chemical Engineering, The MOE Key Laboratory of Spectrochemical Analysis and Instrumentation, State Key Laboratory of Physical Chemistry of Solid ...

“More than 247,000 Canadians will be diagnosed with cancer this year, a devastating reality that hits home as my late-mother and father have been afflicted by this disease,” said Stephen Lecce, ...

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...

NUCLIDIUM, a Swiss clinical-stage biotechnology company pioneering the development of next-generation copper-based radiopharmaceuticals for the diagnosis and treatment of cancer, has raised €84 ...